of the proposed activity suitable for dissemination to the public. It should be a self-contained description of the project and should contain a statement of objectives and methods to be employed. It should be informative to other persons working in the same or related fields and insofar as possible understandable to a technically liter- ate lay reader. This Abstract must not include any proprietary/confidential information. * Please click the add attachment button to complete this entry. 5661-Sickle_Cell_Disease_Association_of_Illinois_ Tracking Number: GRANT00427112 Attachments ProjectAbstractAddAttachment File Name Mime Type 5661-Sickle_Cell_Disease_Association_of_Illinois_Project_ABSTRACT.doc application/msword Tracking Number: GRANT00427112 Project Narrative File(s) FileName MimeType 6212-Mandatory_SCDAI_Conference_Support_ FINAL.doc application/msword Tracking Number: GRANT00427112

Agency
National Institute of Health (NIH)
Institute
Agency for Toxic Substances and Disease Registry (ATSDR)
Type
Conference--Cooperative Agreements (U13)
Project #
1U13TS000082-01
Application #
7585551
Study Section
Special Emphasis Panel (ZHM1-SRC (99))
Project Start
2008-09-01
Project End
2009-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
1
Fiscal Year
2008
Total Cost
$10,000
Indirect Cost
Name
Sickle Cell Disease Association of Illin
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60601